19X Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Axsome Therapeutics Inc

Watchlist Manager

Watchlist

Price: 197.85 EUR 2.09% Market Closed

Market Cap: €9.4B

	Axsome Therapeutics Inc F:19X	US
W	Waters Corp F:WAZ	US
P	Procter & Gamble Co SWB:PRG	US
U	United Natural Foods Inc DUS:UN3	US

Profitability Summary

Axsome Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

93%

Strong 3Y Average Gross Margin

91%

Gross Margin is Increasing

91% > 93%

Negative Operating Margin

-26%

Negative 3Y Average Operating Margin

-77%

Operating Margin is Increasing

-102% > -26%

Negative Net Margin

-29%

Negative 3Y Average Net Margin

-80%

Net Margin is Increasing

-110% > -29%

Negative Free Cash Flow Margin

-15%

Negative 3Y Average Free Cash Flow Margin

-44%

Free Cash Flow Margin is Increasing

-62% > -15%

Negative ROE

-252%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-166%

ROIC is Increasing

-306% > -70%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.